{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:14:45Z","timestamp":1791274485581,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder defined by extracellular deposition of amyloid-\u03b2 (A\u03b2) plaques and intracellular accumulation of hyperphosphorylated Tau in neurofibrillary tangles (NFTs). Notably, approximately 20\u201330% of older individuals harbor substantial amyloid and Tau pathology yet remain cognitively intact, a clinically silent state referred to as asymptomatic Alzheimer\u2019s disease (AsymAD). The biological basis of this cognitive resilience remains poorly understood, in large part due to the absence of mechanistic frameworks and preclinical models that dissociate neuropathology from cognitive decline. Here, we integrate systems-level Boolean network modeling with in vivo validation to define the transcriptomic logic of AsymAD and establish an experimentally tractable murine model of cognitive resilience. Boolean implication networks trained on large-scale human cortical RNA-sequencing datasets identified a robust, invariant AD gene signature that accurately stratified disease states across multiple independent cohorts. Reverse translation of this signature to transgenic mouse models revealed a striking dissociation between molecular pathology and behavioral outcome in Chromogranin A (CgA)\u2013deficient PS19 mice (CgA-KO\/PS19). Male CgA-KO\/PS19 mice exhibited AD-like transcriptomic and neuropathological features in the prefrontal cortex while retaining intact learning and memory. Female CgA-KO\/PS19 mice demonstrated even greater resilience, characterized by suppression of Tau aggregation and preservation of synaptic ultrastructure. Together, these findings establish a validated murine model of AsymAD and identify CgA as a modifiable molecular node linking neuroendocrine signaling, Tauopathy, and cognitive preservation. This integrative computational\u2013experimental framework provides a scalable and generalizable platform for dissecting sex-specific mechanisms of cognitive resilience, identifying early biomarkers of disease trajectory, and enabling mechanism-guided development of preventive therapeutic strategies for AD.<\/jats:p>","DOI":"10.1186\/s40478-026-02286-y","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:15:50Z","timestamp":1775304950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI guided discovery of a murine model of asymptomatic Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Suborno","family":"Jati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satadeepa","family":"Kal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil K.","family":"Mahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"944806","DOI":"10.3389\/fneur.2022.944806","volume":"13","author":"N Olfati","year":"2022","unstructured":"Olfati N, Shoeibi A, Litvan I (2022) Clinical Spectrum of Tauopathies. Front Neurol 13:944806. https:\/\/doi.org\/10.3389\/fneur.2022.944806","journal-title":"Front Neurol"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","volume":"14","author":"VL Villemagne","year":"2018","unstructured":"Villemagne VL, Dore V, Burnham SC, Masters CL, Rowe CC (2018) Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions. Nat Rev Neurol 14:225\u2013236. https:\/\/doi.org\/10.1038\/nrneurol.2018.9","journal-title":"Nat Rev Neurol"},{"key":"2286_CR3","doi-asserted-by":"publisher","unstructured":"Arnold SE, Louneva N, Cao K, Wang LS, Han LY, Wolk DA, Negash S, Leurgans SE, Schneider JA Buchman AS (2013) Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer\u2019s disease. Neurobiol Aging 34: 157\u2013168 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.03.004","DOI":"10.1016\/j.neurobiolaging.2012.03.004"},{"key":"2286_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837\u20131844. https:\/\/doi.org\/10.1212\/01.wnl.0000219668.47116.e6","journal-title":"Neurology"},{"key":"2286_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/01.wnl.0000341273.18141.64","volume":"72","author":"D Erten-Lyons","year":"2009","unstructured":"Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J (2009) Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 72:354\u2013360. https:\/\/doi.org\/10.1212\/01.wnl.0000341273.18141.64","journal-title":"Neurology"},{"key":"2286_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/NEN.0000000000000052","volume":"73","author":"D Iacono","year":"2014","unstructured":"Iacono D, Resnick SM, O\u2019Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC (2014) Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent beta-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol 73:295\u2013304. https:\/\/doi.org\/10.1097\/NEN.0000000000000052","journal-title":"J Neuropathol Exp Neurol"},{"key":"2286_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","volume":"62","author":"DS Knopman","year":"2003","unstructured":"Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LEet al et al (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62:1087\u20131095. https:\/\/doi.org\/10.1093\/jnen\/62.11.1087","journal-title":"J Neuropathol Exp Neurol"},{"key":"2286_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41582-022-00642-9","volume":"18","author":"T Gomez-Isla","year":"2022","unstructured":"Gomez-Isla T, Frosch MP (2022) Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes. Nat Rev Neurol 18:323\u2013332. https:\/\/doi.org\/10.1038\/s41582-022-00642-9","journal-title":"Nat Rev Neurol"},{"key":"2286_CR9","doi-asserted-by":"publisher","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14: 535\u2013562 https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2286_CR10","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1111\/ejn.16482","volume":"60","author":"HB Luleci","year":"2024","unstructured":"Luleci HB, Jones A, Cakir T (2024) Multi-omics analyses highlight molecular differences between clinical and neuropathological diagnoses in Alzheimer\u2019s disease. Eur J Neurosci 60:4922\u20134936. https:\/\/doi.org\/10.1111\/ejn.16482","journal-title":"Eur J Neurosci"},{"key":"2286_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbi.2019.05.009","volume":"80","author":"H Patel","year":"2019","unstructured":"Patel H, Hodges AK, Curtis C, Lee SH, Troakes C, Dobson RJB, Newhouse SJ (2019) Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains. Brain Behav Immun 80:644\u2013656. https:\/\/doi.org\/10.1016\/j.bbi.2019.05.009","journal-title":"Brain Behav Immun"},{"key":"2286_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimers Dement"},{"key":"2286_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2018.10.009","volume":"121","author":"I Barroeta-Espar","year":"2019","unstructured":"Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Siao Tick Chong M, Amaral AC, Murray ME, Moulder KL, Morris JC, Cairns NJet al et al (2019) Distinct cytokine profiles in human brains resilient to Alzheimer\u2019s pathology. Neurobiol Dis 121:327\u2013337. https:\/\/doi.org\/10.1016\/j.nbd.2018.10.009","journal-title":"Neurobiol Dis"},{"key":"2286_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156720511795745348","volume":"8","author":"I Driscoll","year":"2011","unstructured":"Driscoll I, Troncoso J (2011) Asymptomatic Alzheimer\u2019s disease: a prodrome or a state of resilience? Curr Alzheimer Res 8:330\u2013335. https:\/\/doi.org\/10.2174\/156720511795745348","journal-title":"Curr Alzheimer Res"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/NEN.0b013e3181772794","volume":"67","author":"D Iacono","year":"2008","unstructured":"Iacono D, O\u2019Brien R, Resnick SM, Zonderman AB, Pletnikova O, Rudow G, An Y, West MJ, Crain B, Troncoso JC (2008) Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol 67:578\u2013589. https:\/\/doi.org\/10.1097\/NEN.0b013e3181772794","journal-title":"J Neuropathol Exp Neurol"},{"key":"2286_CR16","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/brain\/awt171","volume":"136","author":"BG Perez-Nievas","year":"2013","unstructured":"Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie Met al et al (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology. Brain 136:2510\u20132526. https:\/\/doi.org\/10.1093\/brain\/awt171","journal-title":"Brain"},{"key":"2286_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-180942","volume":"68","author":"EJ Aiello Bowles","year":"2019","unstructured":"Aiello Bowles EJ, Crane PK, Walker RL, Chubak J, LaCroix AZ, Anderson ML, Rosenberg D, Keene CD, Larson EB (2019) Cognitive Resilience to Alzheimer\u2019s Disease Pathology in the Human Brain. J Alzheimers Dis 68:1071\u20131083. https:\/\/doi.org\/10.3233\/JAD-180942","journal-title":"J Alzheimers Dis"},{"key":"2286_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.0000000000005303","volume":"90","author":"EM Arenaza-Urquijo","year":"2018","unstructured":"Arenaza-Urquijo EM, Vemuri P (2018) Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology 90:695\u2013703. https:\/\/doi.org\/10.1212\/WNL.0000000000005303","journal-title":"Neurology"},{"key":"2286_CR19","doi-asserted-by":"publisher","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, Baracchi F, Girouard H, Misoch S, Giacobini E et al (2018) Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol 14: 457\u2013469 https:\/\/doi.org\/10.1038\/s41582-018-0032-9","DOI":"10.1038\/s41582-018-0032-9"},{"key":"2286_CR20","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/WNL.0000000000004802","volume":"90","author":"C Groot","year":"2018","unstructured":"Groot C, van Loenhoud AC, Barkhof F, van Berckel BNM, Koene T, Teunissen CC, Scheltens P, van der Flier WM, Ossenkoppele R (2018) Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease. Neurology 90:e149\u2013e156. https:\/\/doi.org\/10.1212\/WNL.0000000000004802","journal-title":"Neurology"},{"key":"2286_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-024-02775-1","volume":"148","author":"N Jury-Garfe","year":"2024","unstructured":"Jury-Garfe N, Redding-Ochoa J, You Y, Martinez P, Karahan H, Chimal-Juarez E, Johnson TS, Zhang J, Resnick S, Kim J al (2024) Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u2019s disease. Acta Neuropathol 148:15. https:\/\/doi.org\/10.1007\/s00401-024-02775-1","journal-title":"Acta Neuropathol"},{"key":"2286_CR22","doi-asserted-by":"publisher","unstructured":"Ryu T, Kim K, Asiimwe N, Na CH (2025) Proteomic Insight Into Alzheimer\u2019s Disease Pathogenesis Pathways. Proteomics: e202400298 https:\/\/doi.org\/10.1002\/pmic.202400298","DOI":"10.1002\/pmic.202400298"},{"key":"2286_CR23","doi-asserted-by":"publisher","first-page":"114216","DOI":"10.1016\/j.celrep.2024.114216","volume":"43","author":"A Mallach","year":"2024","unstructured":"Mallach A, Zielonka M, van Lieshout V, An Y, Khoo JH, Vanheusden M, Chen WT, Moechars D, Arancibia-Carcamo IL, Fiers M, De Strooper B (2024) Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer\u2019s disease mouse model, as revealed by spatial transcriptomics. Cell Rep 43:114216. https:\/\/doi.org\/10.1016\/j.celrep.2024.114216","journal-title":"Cell Rep"},{"key":"2286_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1210\/er.2010-0027","volume":"32","author":"A Bartolomucci","year":"2011","unstructured":"Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR (2011) The extended granin family: structure, function, and biomedical implications. Endocr Rev 32:755\u2013797. https:\/\/doi.org\/10.1210\/er.2010-0027","journal-title":"Endocr Rev"},{"key":"2286_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/BF00294297","volume":"86","author":"SK Mahata","year":"1993","unstructured":"Mahata SK, Gruber B, Mahata M, Roder C, Fischer-Colbrie R, Sperk G (1993) Kainic acid seizures in the rat: differential expression of chromogranin A, carboxypeptidase H and peptidylglycine alpha-amidating monooxigenase in subfields of the hippocampal formation. Acta Neuropathol (Berl) 86:590\u2013595","journal-title":"Acta Neuropathol (Berl)"},{"key":"2286_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1460-9568.1991.tb00101.x","volume":"3","author":"SK Mahata","year":"1991","unstructured":"Mahata SK, Mahata M, Marksteiner J, Sperk G, Fischer-Colbrie R, Winkler H (1991) Distribution of mRNAs for chromogranins A and B and secretogranin II in rat brain. Eur J Neurosci 3:895\u2013904","journal-title":"Eur J Neurosci"},{"key":"2286_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1748-1716.2007.01806.x","volume":"192","author":"M Montero-Hadjadje","year":"2008","unstructured":"Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y (2008) Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192:309\u2013324 Doi APS1806 [pii]. https:\/\/doi.org\/10.1111\/j.1748-1716.2007.01806.x","journal-title":"Acta Physiol (Oxf)"},{"key":"2286_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0306-4522(92)90222-N","volume":"49","author":"H Winkler","year":"1992","unstructured":"Winkler H, Fischer-Colbrie R (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497\u2013528","journal-title":"Neuroscience"},{"key":"2286_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0006-8993(91)90697-t","volume":"539","author":"JP Brion","year":"1991","unstructured":"Brion JP, Couck AM, Bruce M, Anderton B, Flament-Durand J (1991) Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer\u2019s disease. Brain Res 539:143\u2013150. https:\/\/doi.org\/10.1016\/0006-8993(91)90697-t","journal-title":"Brain Res"},{"key":"2286_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.exger.2003.09.018","volume":"39","author":"T Lechner","year":"2004","unstructured":"Lechner T, Adlassnig C, Humpel C, Kaufmann WA, Maier H, Reinstadler-Kramer K, Hinterholzl J, Mahata SK, Jellinger KA, Marksteiner J (2004) Chromogranin peptides in Alzheimer\u2019s disease. Exp Gerontol 39:101\u2013113. https:\/\/doi.org\/10.1016\/j.exger.2003.09.018","journal-title":"Exp Gerontol"},{"key":"2286_CR31","first-page":"826","volume":"64","author":"DG Munoz","year":"1991","unstructured":"Munoz DG (1991) Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab Invest 64:826\u2013832","journal-title":"Lab Invest"},{"key":"2286_CR32","doi-asserted-by":"publisher","first-page":"e12961","DOI":"10.1111\/nan.12961","volume":"50","author":"O Bousiges","year":"2024","unstructured":"Bousiges O, Lavaux T, Demuynck C, Schaeffer-Agalede C, Philippi N, Muller C, Cretin B, Blanc F (2024) Diagnostic value of CSF chromogranin A to discriminate between Alzheimer\u2019s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 50:e12961. https:\/\/doi.org\/10.1111\/nan.12961","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2286_CR33","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-025-59682-6","volume":"16","author":"S Jati","year":"2025","unstructured":"Jati S, Munoz-Mayorga D, Shahabi S, Tang K, Tao Y, Dickson DW, Litvan I, Ghosh G, Mahata SK, Chen X (2025) Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice. Nat Commun 16:4703. https:\/\/doi.org\/10.1038\/s41467-025-59682-6","journal-title":"Nat Commun"},{"key":"2286_CR34","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/gb-2008-9-10-r157","volume":"9","author":"D Sahoo","year":"2008","unstructured":"Sahoo D, Dill DL, Gentles AJ, Tibshirani R, Plevritis SK (2008) Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol 9:R157. https:\/\/doi.org\/10.1186\/gb-2008-9-10-r157","journal-title":"Genome Biol"},{"key":"2286_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol 27:457\u2013464. https:\/\/doi.org\/10.1002\/ana.410270502","journal-title":"Ann Neurol"},{"key":"2286_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791. https:\/\/doi.org\/10.1126\/science.1074069","journal-title":"Science"},{"key":"2286_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","volume":"28","author":"A Grudzien","year":"2007","unstructured":"Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease. Neurobiol Aging 28:327\u2013335. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.02.007","journal-title":"Neurobiol Aging"},{"key":"2286_CR38","doi-asserted-by":"publisher","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14: 388\u2013405 https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"2286_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2010-1414","volume":"21","author":"K Hensley","year":"2010","unstructured":"Hensley K (2010) Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 21:1\u201314. https:\/\/doi.org\/10.3233\/JAD-2010-1414","journal-title":"J Alzheimers Dis"},{"key":"2286_CR40","doi-asserted-by":"publisher","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B Andrade V (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54: 412\u2013436 https:\/\/doi.org\/10.1038\/s41588-022-01024-z","DOI":"10.1038\/s41588-022-01024-z"},{"key":"2286_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf Aet al et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51:414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nat Genet"},{"key":"2286_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley Bet al et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"2286_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0065-2660(07)59009-7","volume":"59","author":"S Bocklandt","year":"2007","unstructured":"Bocklandt S, Vilain E (2007) Sex differences in brain and behavior: hormones versus genes. Adv Genet 59:245\u2013266. https:\/\/doi.org\/10.1016\/S0065-2660(07)59009-7","journal-title":"Adv Genet"},{"key":"2286_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2007.03.001","volume":"62","author":"KP Cosgrove","year":"2007","unstructured":"Cosgrove KP, Mazure CM, Staley JK (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62:847\u2013855. https:\/\/doi.org\/10.1016\/j.biopsych.2007.03.001","journal-title":"Biol Psychiatry"},{"key":"2286_CR45","doi-asserted-by":"publisher","first-page":"14615","DOI":"10.1073\/pnas.0803652105","volume":"105","author":"L Alonso-Nanclares","year":"2008","unstructured":"Alonso-Nanclares L, Gonzalez-Soriano J, Rodriguez JR, DeFelipe J (2008) Gender differences in human cortical synaptic density. Proc Natl Acad Sci U S A 105:14615\u201314619. https:\/\/doi.org\/10.1073\/pnas.0803652105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2286_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","volume":"14","author":"H Park","year":"2013","unstructured":"Park H, Poo MM (2013) Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14:7\u201323. https:\/\/doi.org\/10.1038\/nrn3379","journal-title":"Nat Rev Neurosci"},{"key":"2286_CR47","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27:1372\u20131384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"key":"2286_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/s1041610298005110","volume":"10","author":"P Davidsson","year":"1998","unstructured":"Davidsson P, Blennow K (1998) Neurochemical dissection of synaptic pathology in Alzheimer\u2019s disease. Int Psychogeriatr 10:11\u201323. https:\/\/doi.org\/10.1017\/s1041610298005110","journal-title":"Int Psychogeriatr"},{"key":"2286_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/jad-2005-7203","volume":"7","author":"PH Reddy","year":"2005","unstructured":"Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr., Kaye J, Manczak M (2005) Differential loss of synaptic proteins in Alzheimer\u2019s disease: implications for synaptic dysfunction. J Alzheimers Dis 7:103\u2013117 discussion 173\u2013180. https:\/\/doi.org\/10.3233\/jad-2005-7203","journal-title":"J Alzheimers Dis"},{"key":"2286_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuint.2013.10.013","volume":"64","author":"MG Tan","year":"2014","unstructured":"Tan MG, Lee C, Lee JH, Francis PT, Williams RJ, Ramirez MJ, Chen CP, Wong PT, Lai MK (2014) Decreased rabphilin 3A immunoreactivity in Alzheimer\u2019s disease is associated with Abeta burden. Neurochem Int 64:29\u201336. https:\/\/doi.org\/10.1016\/j.neuint.2013.10.013","journal-title":"Neurochem Int"},{"key":"2286_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-025-01684-z","volume":"17","author":"C Boccalini","year":"2025","unstructured":"Boccalini C, Peretti DE, Scheffler M, Mu L, Griffa A, Testart N, Allali G, Prior JO, Ashton NJ, Zetterberg Het al et al (2025) Sex differences in the association of Alzheimer\u2019s disease biomarkers and cognition in a multicenter memory clinic study. Alzheimers Res Ther 17:46. https:\/\/doi.org\/10.1186\/s13195-025-01684-z","journal-title":"Alzheimers Res Ther"},{"key":"2286_CR52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","volume":"136","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA (2018) Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging. Acta Neuropathol 136:887\u2013900. https:\/\/doi.org\/10.1007\/s00401-018-1920-1","journal-title":"Acta Neuropathol"},{"key":"2286_CR53","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/brain\/awad031","volume":"146","author":"JK Wong","year":"2023","unstructured":"Wong JK, Lin J, Kung NJ, Tse AL, Shimshak SJE, Roselle AK, Cali FM, Huang J, Beaty JM, Shue TM, Sadiq SA (2023) Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic. Brain 146:1979\u20131992. https:\/\/doi.org\/10.1093\/brain\/awad031","journal-title":"Brain"},{"key":"2286_CR54","doi-asserted-by":"publisher","unstructured":"Bottero V, Powers D, Yalamanchi A, Quinn JP, Potashkin JA (2021) Key Disease Mechanisms Linked to Alzheimer\u2019s Disease in the Entorhinal Cortex. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22083915","DOI":"10.3390\/ijms22083915"},{"key":"2286_CR55","doi-asserted-by":"publisher","first-page":"1191680","DOI":"10.3389\/fnagi.2023.1191680","volume":"15","author":"H Wu","year":"2023","unstructured":"Wu H, Wang J, Hu X, Zhuang C, Zhou J, Wu P, Li S, Zhao RC (2023) Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer\u2019s disease. Front Aging Neurosci 15:1191680. https:\/\/doi.org\/10.3389\/fnagi.2023.1191680","journal-title":"Front Aging Neurosci"},{"key":"2286_CR56","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/nbt.2038","volume":"29","author":"P Dalerba","year":"2011","unstructured":"Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA, Sim S, Okamoto J, Johnston DM, Qian Det al et al (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 29:1120\u20131127. https:\/\/doi.org\/10.1038\/nbt.2038","journal-title":"Nat Biotechnol"},{"key":"2286_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1506597","volume":"374","author":"P Dalerba","year":"2016","unstructured":"Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgo E, Rajendran PS, Miranda SP al (2016) CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med 374:211\u2013222. https:\/\/doi.org\/10.1056\/NEJMoa1506597","journal-title":"N Engl J Med"},{"key":"2286_CR58","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1101\/gad.1836009","volume":"23","author":"MA Inlay","year":"2009","unstructured":"Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, Karsunky H, Plevritis SK, Dill DL, Weissman IL (2009) Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev 23:2376\u20132381. https:\/\/doi.org\/10.1101\/gad.1836009","journal-title":"Genes Dev"},{"key":"2286_CR59","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1073\/pnas.0913635107","volume":"107","author":"D Sahoo","year":"2010","unstructured":"Sahoo D, Seita J, Bhattacharya D, Inlay MA, Weissman IL, Plevritis SK, Dill DL (2010) MiDReG: a method of mining developmentally regulated genes using Boolean implications. Proc Natl Acad Sci U S A 107:5732\u20135737. https:\/\/doi.org\/10.1073\/pnas.0913635107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2286_CR60","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1038\/s41467-021-24470-5","volume":"12","author":"D Sahoo","year":"2021","unstructured":"Sahoo D, Swanson L, Sayed IM, Katkar GD, Ibeawuchi SR, Mittal Y, Pranadinata RF, Tindle C, Fuller M, Stec DL al (2021) Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease. Nat Commun 12:4246. https:\/\/doi.org\/10.1038\/s41467-021-24470-5","journal-title":"Nat Commun"},{"key":"2286_CR61","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.18632\/oncotarget.23973","volume":"9","author":"D Sahoo","year":"2018","unstructured":"Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko Jet al et al (2018) Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget 9:6550\u20136561. https:\/\/doi.org\/10.18632\/oncotarget.23973","journal-title":"Oncotarget"},{"key":"2286_CR62","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1073\/pnas.1120605109","volume":"109","author":"JP Volkmer","year":"2012","unstructured":"Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA al (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A 109:2078\u20132083. https:\/\/doi.org\/10.1073\/pnas.1120605109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2286_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s1550-8579(06)80198-1","volume":"3","author":"SN Austad","year":"2006","unstructured":"Austad SN (2006) Why women live longer than men: sex differences in longevity. Gend Med 3:79\u201392. https:\/\/doi.org\/10.1016\/s1550-8579(06)80198-1","journal-title":"Gend Med"},{"key":"2286_CR64","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cmet.2016.05.019","volume":"23","author":"SN Austad","year":"2016","unstructured":"Austad SN, Fischer KE (2016) Sex Differences in Lifespan. Cell Metab 23:1022\u20131033. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.019","journal-title":"Cell Metab"},{"key":"2286_CR65","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1002\/alz.13844","volume":"20","author":"EM Arenaza-Urquijo","year":"2024","unstructured":"Arenaza-Urquijo EM, Boyle R, Casaletto K, Anstey KJ, Vila-Castelar C, Colverson A, Palpatzis E, Eissman JM, Kheng Siang Ng T, Raghavan Set al et al (2024) Sex and gender differences in cognitive resilience to aging and Alzheimer\u2019s disease. Alzheimers Dement 20:5695\u20135719. https:\/\/doi.org\/10.1002\/alz.13844","journal-title":"Alzheimers Dement"},{"key":"2286_CR66","doi-asserted-by":"publisher","first-page":"101184","DOI":"10.1016\/j.yfrne.2025.101184","volume":"77","author":"S Emrani","year":"2025","unstructured":"Emrani S, Sundermann EE (2025) Sex\/gender differences in the clinical trajectory of Alzheimer\u2019s disease: Insights into diagnosis and cognitive reserve. Front Neuroendocrinol 77:101184. https:\/\/doi.org\/10.1016\/j.yfrne.2025.101184","journal-title":"Front Neuroendocrinol"},{"key":"2286_CR67","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3233\/JAD-160716","volume":"56","author":"EE Sundermann","year":"2017","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Landau S, Maki PM, Alzheimer\u2019s Disease Neuroimaging I (2017) Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer\u2019s Disease Pathology in Women versus Men? J Alzheimers Dis 56:947\u2013957. https:\/\/doi.org\/10.3233\/JAD-160716","journal-title":"J Alzheimers Dis"},{"key":"2286_CR68","doi-asserted-by":"publisher","unstructured":"Vila-Castelar C, Tariot PN, Sink KM, Clayton D, Langbaum JB, Thomas RG, Chen Y, Su Y, Chen K, Hu N et al (2022) Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer\u2019s disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. Alzheimers Dement 18: 2272\u20132282 https:\/\/doi.org\/10.1002\/alz.12552","DOI":"10.1002\/alz.12552"},{"key":"2286_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000106963","volume":"6","author":"K Blennow","year":"1995","unstructured":"Blennow K, Davidsson P, Wallin A, Ekman R (1995) Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer\u2019s disease? Dementia 6:306\u2013311. https:\/\/doi.org\/10.1159\/000106963","journal-title":"Dementia"},{"key":"2286_CR70","doi-asserted-by":"publisher","first-page":"32058","DOI":"10.1074\/jbc.M305545200","volume":"278","author":"SK Mahata","year":"2003","unstructured":"Mahata SK, Mahapatra NR, Mahata M, Wang TC, Kennedy BP, Ziegler MG, O\u2019Connor DT (2003) Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter\/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J Biol Chem 278:32058\u201332067","journal-title":"J Biol Chem"},{"key":"2286_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.regpep.2010.01.006","volume":"162","author":"SK Mahata","year":"2010","unstructured":"Mahata SK, Mahata M, Fung MM, O\u2019Connor DT (2010) Catestatin: a multifunctional peptide from chromogranin A. Regul Pept 162:33\u201343 Doi S0167-0115(10)00033\u2009\u2013\u20099 [pii]. https:\/\/doi.org\/10.1016\/j.regpep.2010.01.006","journal-title":"Regul Pept"},{"key":"2286_CR72","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1172\/JCI119686","volume":"100","author":"SK Mahata","year":"1997","unstructured":"Mahata SK, O\u2019Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623\u20131633","journal-title":"J Clin Invest"},{"key":"2286_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.it.2021.11.002","volume":"43","author":"EM Muntjewerff","year":"2022","unstructured":"Muntjewerff EM, Christoffersson G, Mahata SK, van den Bogaart G (2022) Putative regulation of macrophage-mediated inflammation by catestatin. Trends Immunol 43:41\u201350. https:\/\/doi.org\/10.1016\/j.it.2021.11.002","journal-title":"Trends Immunol"},{"key":"2286_CR74","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2337\/db17-0788","volume":"67","author":"W Ying","year":"2018","unstructured":"Ying W, Mahata S, Bandyopadhyay GK, Zhou Z, Wollam J, Vu J, Mayoral R, Chi NW, Webster NJG, Corti A, Mahata SK (2018) Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity. Diabetes 67:841\u2013848. https:\/\/doi.org\/10.2337\/db17-0788","journal-title":"Diabetes"},{"key":"2286_CR75","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/HYPERTENSIONAHA.120.16809","volume":"77","author":"W Ying","year":"2021","unstructured":"Ying W, Tang K, Avolio E, Schilling JM, Pasqua T, Liu MA, Cheng H, Gao H, Zhang J, Mahata S al (2021) Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin). Hypertension 77:1670\u20131682. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16809","journal-title":"Hypertension"},{"key":"2286_CR76","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.04.697519","author":"S Jati","year":"2026","unstructured":"Jati S, Kal S, Munoz-Mayorga D, Tang K, Sahoo D, Chen X, Mahata SK (2026) Catestatin ameliorates tauopathy and amyloidogenesis via adrenergic inhibition. bioRxiv: Doi. https:\/\/doi.org\/10.64898\/2026.01.04.697519","journal-title":"bioRxiv: Doi"},{"key":"2286_CR77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2014.04.001","volume":"270","author":"E Avolio","year":"2014","unstructured":"Avolio E, Mahata SK, Mantuano E, Mele M, Alo R, Facciolo RM, Talani G, Canonaco M (2014) Antihypertensive and neuroprotective effects of catestatin in spontaneously hypertensive rats: Interaction with GABAergic transmission in amygdala and brainstem. Neuroscience 270:48\u201357. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.001","journal-title":"Neuroscience"},{"key":"2286_CR78","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/10799893.2021.1878536","volume":"42","author":"E Du","year":"2022","unstructured":"Du E, Wang A, Fan R, Rong L, Yang R, Xing J, Shi X, Qiao B, Yu R, Xu C (2022) Catestatin enhances ATP-induced activation of glial cells mediated by purinergic receptor P2X(4). J Recept Signal Transduct Res 42:160\u2013168. https:\/\/doi.org\/10.1080\/10799893.2021.1878536","journal-title":"J Recept Signal Transduct Res"},{"key":"2286_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00441-018-2956-1","volume":"376","author":"BS Sahu","year":"2019","unstructured":"Sahu BS, Mahata S, Bandyopadhyay K, Mahata M, Avolio E, Pasqua T, Sahu C, Bandyopadhyay GK, Bartolomucci A, Webster NJG al (2019) Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells. Cell Tissue Res 376:51\u201370. https:\/\/doi.org\/10.1007\/s00441-018-2956-1","journal-title":"Cell Tissue Res"},{"key":"2286_CR80","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer\u2019s disease in individuals under thirty. Acta Neuropathol 121:171\u2013181. https:\/\/doi.org\/10.1007\/s00401-010-0789-4","journal-title":"Acta Neuropathol"},{"key":"2286_CR81","doi-asserted-by":"publisher","unstructured":"Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL et al (2019) Sex differences in the genetic predictors of Alzheimer\u2019s pathology. Brain 142: 2581\u20132589 https:\/\/doi.org\/10.1093\/brain\/awz206","DOI":"10.1093\/brain\/awz206"},{"key":"2286_CR82","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam AL, Kohane IS (2018) Big Data and Machine Learning in Health Care. JAMA 319:1317\u20131318. https:\/\/doi.org\/10.1001\/jama.2017.18391","journal-title":"JAMA"},{"key":"2286_CR83","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrg2825","volume":"11","author":"JT Leek","year":"2010","unstructured":"Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, Geman D, Baggerly K, Irizarry RA (2010) Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 11:733\u2013739. https:\/\/doi.org\/10.1038\/nrg2825","journal-title":"Nat Rev Genet"},{"key":"2286_CR84","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I (2019) Machine Learning in Medicine. N Engl J Med 380:1347\u20131358. https:\/\/doi.org\/10.1056\/NEJMra1814259","journal-title":"N Engl J Med"},{"key":"2286_CR85","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1172\/JCI24354","volume":"115","author":"NR Mahapatra","year":"2005","unstructured":"Mahapatra NR, O\u2019Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N al (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115:1942\u20131952. https:\/\/doi.org\/10.1172\/JCI24354","journal-title":"J Clin Invest"},{"key":"2286_CR86","doi-asserted-by":"publisher","first-page":"D562","DOI":"10.1093\/nar\/gki022","volume":"33","author":"T Barrett","year":"2005","unstructured":"Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, Edgar R (2005) NCBI GEO: mining millions of expression profiles\u2013database and tools. Nucleic Acids Res 33:D562\u2013566. https:\/\/doi.org\/10.1093\/nar\/gki022","journal-title":"Nucleic Acids Res"},{"key":"2286_CR87","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko Met al et al (2013) NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res 41:D991\u2013995. https:\/\/doi.org\/10.1093\/nar\/gks1193","journal-title":"Nucleic Acids Res"},{"key":"2286_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207","journal-title":"Nucleic Acids Res"},{"key":"2286_CR89","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gng015","volume":"31","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15","journal-title":"Nucleic Acids Res"},{"key":"2286_CR90","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323","journal-title":"BMC Bioinformatics"},{"key":"2286_CR91","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621\u2013628. https:\/\/doi.org\/10.1038\/nmeth.1226","journal-title":"Nat Methods"},{"key":"2286_CR92","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511\u2013515. https:\/\/doi.org\/10.1038\/nbt.1621","journal-title":"Nat Biotechnol"},{"key":"2286_CR93","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","volume":"131","author":"GP Wagner","year":"2012","unstructured":"Wagner GP, Kin K, Lynch VJ (2012) Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples. Theory Biosci 131:281\u2013285. https:\/\/doi.org\/10.1007\/s12064-012-0162-3","journal-title":"Theory Biosci"},{"key":"2286_CR94","doi-asserted-by":"publisher","unstructured":"Law CW, Alhamdoosh M, Su S, Dong X, Tian L, Smyth GK, Ritchie ME (2016) RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Res 5. https:\/\/doi.org\/10.12688\/f1000research.9005.3","DOI":"10.12688\/f1000research.9005.3"},{"key":"2286_CR95","doi-asserted-by":"publisher","first-page":"e00123","DOI":"10.1002\/pld3.123","volume":"3","author":"S Pandey","year":"2019","unstructured":"Pandey S, Sahoo D (2019) Identification of gene expression logical invariants in Arabidopsis. Plant Direct 3:e00123. https:\/\/doi.org\/10.1002\/pld3.123","journal-title":"Plant Direct"},{"key":"2286_CR96","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1093\/nar\/gkm284","volume":"35","author":"D Sahoo","year":"2007","unstructured":"Sahoo D, Dill DL, Tibshirani R, Plevritis SK (2007) Extracting binary signals from microarray time-course data. Nucleic Acids Res 35:3705\u20133712. https:\/\/doi.org\/10.1093\/nar\/gkm284","journal-title":"Nucleic Acids Res"},{"key":"2286_CR97","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1091\/mbc.E19-01-0013","volume":"30","author":"SA Dabydeen","year":"2019","unstructured":"Dabydeen SA, Desai A, Sahoo D (2019) Unbiased Boolean analysis of public gene expression data for cell cycle gene identification. Mol Biol Cell 30:1770\u20131779. https:\/\/doi.org\/10.1091\/mbc.E19-01-0013","journal-title":"Mol Biol Cell"},{"key":"2286_CR98","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.26.577475","author":"A Horowitz","year":"2024","unstructured":"Horowitz A, Yu H, Pandey S, Mishra B, Sahoo D (2024) C1QA is an invariant biomarker for tissue macrophages. bioRxiv: Doi. https:\/\/doi.org\/10.1101\/2024.01.26.577475","journal-title":"bioRxiv: Doi"},{"key":"2286_CR99","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00441-015-2316-3","volume":"363","author":"T Pasqua","year":"2016","unstructured":"Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE, Mahata SK (2016) Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo. Cell Tissue Res 363:693\u2013712. https:\/\/doi.org\/10.1007\/s00441-015-2316-3","journal-title":"Cell Tissue Res"},{"key":"2286_CR100","doi-asserted-by":"publisher","unstructured":"Wollam J, Mahata S, Riopel M, Hernandez-Carretero A, Biswas A, Bandyopadhyay GK, Chi NW, Eiden LE, Mahapatra NR, Corti A et al (2017) Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion. Cell Tissue Res 368: 487\u2013501 https:\/\/doi.org\/10.1007\/s00441-017-2580-5","DOI":"10.1007\/s00441-017-2580-5"},{"key":"2286_CR101","doi-asserted-by":"publisher","unstructured":"Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B et al (2018) The Reactome Pathway Knowledgebase. Nucleic Acids Res 46: D649-D655 https:\/\/doi.org\/10.1093\/nar\/gkx1132","DOI":"10.1093\/nar\/gkx1132"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02286-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:29:00Z","timestamp":1781645340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02286-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02286-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Since we used postmortem brain tissue, consent was not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.S is a co-founder of the company RNACheck. S.K.M. is the founder of CgA Therapeuticals, Inc. and co-founder of Siraj Therapeutics. The remaining authors declare no competing interests. A U.S. patent (No. PCT\/US2025\/053203) was filed on October 29, 2025, listing Sushil K. Mahata, and Suborno Jati as co-inventors. A new disclosure with Case Number SD2025-405 was submitted to UCSD on June 9, 2025.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}